We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.75 | 6.66 | 7.38 | - | 22,899 | 10:28:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.77 | 13.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2020 08:36 | EU Clinical Trials RegisterType in SNG001 for trials SNG001 has in progress. Note COVID19 has taken priority. hTTps://www.clinical | tidy 2 | |
24/3/2020 08:29 | Huge deal with ASTRAZENACA (again) in "days" ? SPOT THE DIFFERENCE (clue....NONE!) SYNAIRGEN (18 MAR 20): "in discussion with, a number of other medical, scientific, and Governmental bodies (both in the UK, US and internationally) " ASTRAZENACA (21 MAR 20): " understood to be in talks with Western governments and academic institutions about research agreements that could be announced in the coming days." SYNAIRGEN/ASTRAZENAC DEAL (APRIL 2017): SYNAIRGEN previously signed a $232m with ASTRAZENACA before they pulled out in April 2017. Is the almost identical wording of SYNAIRGEN and ASTRAZENACA in the past few days just a co-incidence considering they almost did a $232m deal together just 2 years ago? Can you afford to risk being out should a deal MASSIVELY bigger than the $232m be announced "in the coming days" ? | lithological heterogeneities | |
23/3/2020 22:47 | hTTps://www.bloomber | tidy 2 | |
23/3/2020 22:24 | COVID19 stocks are the only game in town right now. | tidy 2 | |
23/3/2020 22:23 | I see SNG gets a mention alongside faron and Tiziana in the Daily Mail's Small Cap Ideas. | pdt | |
23/3/2020 21:16 | Lots of positives here, clearly demonstrated by the relentless rises of last week, which I expect will resume shortly. With so much success in mitigating nearly identical illnesses already well established, the odds of demonstrating a significant impact on COVID-19 patients seem very high. Why else would there be so much testing pushed through at such short notice and endorsed by a decent breadth of expertise, for-profit and not for-profit alike. With resources and time so scarce, they are not going to chase losers. | nick9013 | |
23/3/2020 19:34 | Well I got my 50 close (just about!) | toffeeman | |
23/3/2020 17:42 | asif12 23 Mar '20 - 14:12 - 403 of 409 that is not true!!!! | yet another final | |
23/3/2020 17:39 | goofrob, no harm in that Had I sold this am and bought back later this afternoon, would have had 20+% more (aint hindsight so clear!!) but happy watching and holding cos believe in the principle of therapy and its scope. Nearer the time of results etc, it will get more volatile, with better trading opportunities. All depends on each investors strategy...GLA | yet another final | |
23/3/2020 16:48 | Well as I said it is always going to be volatile. I maintain it will be way higher before the result in 2 months or so and that is the date to focus on. What is a company worth which has a treatment for Covid 19. It is probably at least 10 fold up from here and even if you think the chance of success is only 50:50 that means the risk reward is still massively positive! | nobbygnome | |
23/3/2020 16:42 | Dont get too complacent here....call me old fashioned..I sold half my holding earlier and made 2.7k....hope we all do really well but be careful....rampers galore around!! Stay safe. | goofrob | |
23/3/2020 16:35 | Me2 at 51p That's 3 top ups for me today | bmnsa | |
23/3/2020 16:29 | just had a few more before close, couldn't resist | thwarnts | |
23/3/2020 16:28 | Link are dumping big time like rats | iamgreat1 | |
23/3/2020 16:25 | The good old gap. The gamble was would they fill it or would you be left buying higher thinking they would will it when they decided not to. If the mms want stock they will keep squeezing you out until it is filled. Same happened on the previous spike as the free float is minuscule. | tidy 2 | |
23/3/2020 16:13 | Gap filled...strong close coming up. | likya123 | |
23/3/2020 16:12 | Never thought people would be getting a second chance to buy here! | dave444 | |
23/3/2020 16:10 | Just a case of filling the gap which is better if it is necessary. | tidy 2 | |
23/3/2020 15:49 | That is bound to happen. You always get a second wave in a pandemic. | nobbygnome | |
23/3/2020 15:30 | Cytokines are crucial for activating cells and drivig the immune response. Beta interferon is itself one of the many cytokines. | nobbygnome | |
23/3/2020 15:30 | Not antibodies but cytokines (I think) produced by the cells activated by the beta interferon. It takes a couple of weeks to generate antibodies. | nobbygnome | |
23/3/2020 15:26 | CEO states after 1 dose of SNG001 patients were showing signs of antibodies produced by the time their second dose was ready to be administered the following day. Excellent. | tidy 2 | |
23/3/2020 15:16 | Gilead's market cap has increased by about $10 billion since announcing their drug Remdesivir may be helpful. So don't feel too sorry for them. | pdt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions